Browsing Tag
Dr. Reddy’s Laboratories
68 posts
Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI
Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for…
Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US
Dr. Reddy’s Laboratories, an Indian pharma company, has launched Fluphenazine Hydrochloride Tablets, USP, in the US market. Fluphenazine…
Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V Covid-19 vaccine
Dr. Reddy’s Laboratories has recently received approval from the Drugs Control General of India (DCGI) to proceed with…
Dr. Reddy’s reports success in Sputnik V phase 2 trial, paving the way for phase 3 in India
Dr. Reddy’s Laboratories has announced a major milestone in the development of Sputnik V, the Russian Covid-19 vaccine,…
Dr. Reddy’s launches Sapropterin Dihydrochloride Tablets generic version in US
Indian pharma company Dr. Reddy’s Laboratories has launched a generic version of phenylalanine hydroxylase activator Sapropterin Dihydrochloride Tablets,…
Dr. Reddy’s, RDIF to bring Sputnik V coronavirus vaccine to India
Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories have agreed to cooperate on clinical trials and distribution…
Dr Reddy’s Laboratories to acquire generic injectable products in the US
Dr Reddy’s Laboratories has agreed to acquire a portfolio of 42 approved, non-marketed abbreviated new drug applications (ANDAs)…
Marc Kikuchi appointed CEO of Dr. Reddy’s North America Generics unit
Dr. Reddy’s Laboratories has announced the appointment of Marc Kikuchi as the CEO of its North America Generics…